SmPC- Telmisartan 40mgTablets: Change history
View Summary of Product Characteristics (SmPC- Telmisartan 40mgTablets)
Last updated on this site: 29 Dec 2025
Description of update: To update the SmPC and PIL in line with the reference product, Micardis.
Date of approval: 22/12/2025
SmPC sections updated: 4.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.1, 5.2, 5.3 and 10
PIL sections updated: 1, 2, 3, 4, 5 and 6
Last updated on this site: 29 Dec 2025
Description of update: To update the SmPC and PIL in line with the reference product, Micardis.
Date of approval: 22/12/2025
SmPC sections updated: 4.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.1, 5.2, 5.3 and 10
PIL sections updated: 1, 2, 3, 4, 5 and 6
-
Changes: (Updated: 29 Dec 2025)
Description of update: To update the SmPC and PIL in line with the reference product, Micardis.
Date of approval: 22/12/2025
SmPC sections updated: 4.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.1, 5.2, 5.3 and 10
PIL sections updated: 1, 2, 3, 4, 5 and 6
-
Changes: (Updated: 13 May 2025)
Type IAIN variation to Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITTNo 20104) for intestinal angioedema.
-
Changes: (Updated: 19 Dec 2022)
SmPC sections updated – 9 and 10
MHRA Renewal approval date – 14/12/2022
-
Changes: (Updated: 22 Sep 2022)
initial upload